Services and laboratories » Centro per lo studio della Malattia di Alzheimer e demenze correlate » Publications


Delgado R, Carlin A, Airaghi L, Demitri MT, Meda L, Galimberti D, Baron PL, Lipton JM, Catania A. Melanocortin peptides inhibit production of proinflammatory cytokines and nitric oxide by activated microglia. Journal of Leukocyte Biology 1998;63:740-745.

Galimberti D, Baron PL, Meda L, Prat E, Scarpini E, Delgado R, Catania A, Lipton JM, Scarlato G. a-MSH peptides inhibit production of nitric oxide and tumor necrosis factor-a by microglial cells activated with ß-amyloid and interferon-y. Biochemical and Biophysical Research Communications 1999;263:251-256.

Prat E, Baron P., Meda L, Scarpini E, Galimberti D, Ardolino G, Catania A, Scarlato G. The human astrocytoma cell line U373MG produces monocyte chemotactic protein (MCP-1) upon stimulation with ß-amyloid protein. Neuroscience Letters 2000;283:177-180.

Baron PL, Galimberti D, Meda L, Prat E, Scarpini E, Conti G, Moggio M, Prelle A, Scarlato G. Synergistic effect of  ß-amyloid protein and interferon-y or nitric oxide production by C2C12 muscle cells. Brain  2000;123:374-379.

Baron P, Galimberti D, Meda L, Scarpini E, Conti G, Cogiamanian F, Scarlato G. Production of IL-6 by human myoblasts stimulated with Ab: relevance in the pathogenesis of IBM. Neurology 2001;57:1561-1565.

Rigamonti AE, Pincelli AI, Corrà B, Viarengo R, Bonomo SM, Galimberti D, Scacchi M, Scarpini E, Cavagnini F, Müller EE. Plasma ghrelin concentrations in elderly subjects: comparison with anorexic and obese patients. Journal  of Endocrinology 2002;175:R1-5.

Galimberti D, Schoonenboom N, Scarpini E, Scheltens P, on behalf of the DIAR Group. Chemokines in CSF and serum from patients with different types of dementia. Annals of Neurology 2003;53:547-548.

Scarpini E, Scheltens P, Feldman H. Treatment of Alzheimer's disease: current status and new perspectives. Lancet Neurology 2003;2(9):539-47. 

Fenoglio C, Galimberti D, Lovati C, Guidi I, Gatti A, Fogliarino S, Tiriticco M, Mariani C, Forloni G, Pettenati C, Baron PL, Conti G, Bresolin N, Scarpini E. MCP-1 in Alzheimer’s disease patients: A-2518G polymorphism and serum levels. Neurobiology of Aging 2004;25(9):1169-1173.

Feldman H, Scheltens P, Scarpini E, Hermann N, Mesenbrink P, Mancione L, Tekin S, Lane R, Ferris S. Behavioral symptoms in mild cognitive impairment. Neurology 2004;62(7):1199-201. Erratum in: Neurology. 2004;63(4):764. 

Galimberti D, Fenoglio C, Lovati C, Gatti A, Guidi I, Venturelli E, Cutter GR, Mariani C, Forloni G, Pettenati C, Baron PL, Conti G, Bresolin N, Scarpini E. CCR2-64I polymorphism and CCR5∆32 deletion in patients with Alzheimer’s disease. Journal of the Neurological Sciences 2004;225:79-83.

Guidi I, Galimberti D, Venturelli E, Lovati C, Del Bo R, Fenoglio C, Gatti A, Dominici R, Galbiati S, Virgilio R, Pomati S, Comi GP,Mariani C, Forloni G, Bresolin N, Scarpini E. Influence of the Glu298Asp polymorphism of NOS3 on age at onset and homocysteine levels in AD patients. Neurobiology of Aging, 2005;26(6):789-794.

Del Bo R, Scarlato, M, Ghezzi S, Martinelli Boneschi F, Fenoglio C, Galbiati S, Virgilio R, Galimberti D, Galimberti G, Crimi M, Ferrarese C, Scarpini E, Bresolin N, Comi GP. VEGF gene variability is associated with increased risk of Alzheimer’s disease. Annals of Neurology, 2005;57:373-78

Venturelli E, Galimberti D, Lovati C, Fenoglio C, Mariani C, Forloni G, Bresolin N, Scarpini E. The T-786C NOS3 polymorphism in Alzheimer’s disease: association and influence on gene expression. Neuroscience Letters 2005;382:300-303.

Galimberti D, Venturelli E, Gatti A, Lovati C, Fenoglio C, Mariani C, Forloni G, Bresolin N, Scarpini E. Association of neuronal Nitric Oxide Synthase C276T polymorphism with Alzheimer’s disease. Journal of Neurology 2005; 252:985-986.

Scalabrini D, Galimberti D, Fenoglio C, Comi C, De Riz M, Venturelli E, Castelli L, Piccio L, Ronzoni M, Lovati C, Mariani C, Monaco F, Bresolin N, Scarpini E. P-selectin glycoprotein ligand-1 variable number of tandem repeats (VNTR) polymorphism in patients with Multiple Sclerosis. Neuroscience Letters 2005; 388: 149-152.

Anchisi D, Borroni B, Franceschi M, Kerrouche N, Kalbe E, Beuthien-Beumann B, Cappa S, Lenz O, Ludecke S, Marcone A, Mielke R, Ortelli P, Padovani A, Pelati O, Pupi A, Scarpini E, Weisenbach S, Herholz K, Salmon E, Holthoff V, Sorbi S, Fazio F, Perani D. Heterogeneity of brain glucose metabolism in mild cognitive impairment and clinical progression to Alzheimer disease. Archives of Neurology 2005;62(11):1728-33.

Bussini S, Meda L, Scarpini E, Clementi E, Conti G, Tiriticco M, Bresolin N, Baron P. Heparan sulfate proteoglycan induces the production of NO and TNF-alpha by murine microglia. Immunity & Ageing 2005;2:11. 

Guidi I, Galimberti D, Lonati S, Novembrino C, Bamonti F, Tiriticco M, Fenoglio C, Venturelli E, Baron PL, Bresolin N, Scarpini E. Oxidative imbalance in patients with Mild Cognitive Impairment and Alzheimer's  disease. Neurobiology of Aging 2006;27(2):262-269.

Del Bo, Scarlato M, Ghezzi S, Martinelli-Boneschi F, Fenoglio C, Galimberti G, Galbiati S, Virgilio R, Galimberti D, Ferrarese C, Scarpini E, Bresolin N, Comi GP. Is M129V of PRNP gene associated with Alzheimer's disease? A case-control study and a meta-analysis.Neurobiology of Aging 2006;27(5):770.

Scarpini E, Galimberti D, Guidi I, Bresolin N, Scheltens P. Progressive, isolated language disturbance: its significance in a 65-year-old-man. A case report with implications for treatment and review of literature. Journal of the Neurological Sciences 2006;240:45-51.

Galimberti D, Schoonenboom N, Scheltens P, Fenoglio C, Venturelli E, Pijnenburg YAL, Bresolin N, Scarpini E. Intrathecal chemokine levels in Alzheimer’s disease and Frontotemporal Lobar degeneration. Neurology 2006; 66(1):146-147.

Saltini G, Dominici R, Lovati C, Cattaneo M, Michelini S, Malferrari G, Caprera A, Milanesi L, Finazzi D, Bertora P,Scarpini E, Galimberti D, Venturelli E, Musicco M, Adorni F, Mariani C, Biunno I. A novel polymorphism in SEL1L confers susceptibility to Alzheimer’s disease. Neuroscience Letters 2006;398(1-2):53-8.

Pesaresi M, Lovati C, Bertora P, Mailland E, Galimberti D, Scarpini E, Quadri P, Forloni G, Mariani C. Plasma levels of beta-amyloid (1-42) in Alzheimer's disease and mild cognitive impairment. Neurobiology of Aging 2006; 27: 904-905.

Galimberti D, Fenoglio C, Lovati C, Venturelli E, Guidi I, Corrà B, Scalabrini D, Clerici F, Mariani C, Bresolin N, Scarpini E. Serum MCP-1 levels are increased in Mild Cognitive Impairment and mild Alzheimer's disease. Neurobiology of Aging 2006, in corso di stampa.

Galimberti D, Schoonenboom N, Scheltens P, Fenoglio C, Bouwman F, Venturelli E, Guidi I, Blankenstein MA, Bresolin N, Scarpini E. Intrathecal chemokine synthesis in Mild Cognitive Impairment and Alzheimer's disease. Archives of Neurology 2006;63:538-543.

E. Scarpini, D. Galimberti, N. Bresolin.Genetics and neurobiology of Frontotemporal Lobar Degeneration. Neurological Sciences 2006, 27 Suppl.1: S32-S34.

Giunta M, Rigamonti AE, Scarpini E, Galimberti D, Bonomo SM, Venturelli E, Müller EE, Cella SG. The leukocyte expression of CD36 is low in patients with Alzheimer’s disease and Mild Cognitive Impairment. Neurobiology of Aging 2006, in corso di stampa.

Venturelli E, Galimberti D, Fenoglio C, Lovati C, Finazzi D, Guidi I, Corrà B, Scalabrini D, Clerici F, Mariani C, Forloni G, Bresolin N, Scarpini E. Candidate gene analysis of  IP-10 gene in patients with Alzheimer's disease. Neuroscience Letters 2006, in corso di stampa.

Albani D, Batelli S, Prato F, Pesaresi M, Galimberti D, Scarpini E, Bruni A, Franceschi M, Piras MR, Confaloni A, Roiter I, Artuso V, Forloni G.  Presenilin-1 mutation E318G and familial Alzheimer's disease in the Italian population. Neurobiology of Aging, in corso di stampa.